Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

HSP

Hospira (HSP)

De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:HSP
DataHoraFonteTítuloCódigoCompanhia
13/05/201514:40PR Newswire (US)Hospira Shareholders Approve Merger of Hospira and Pfizer at Special MeetingNYSE:HSP
11/05/201515:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:HSP
30/04/201509:49Analyst Ratings NetworkHospira Upgraded to Strong-Buy at Zacks (HSP)NYSE:HSP
28/04/201511:12Dow Jones NewsPfizer Trims Outlook on Stronger Dollar -- UpdateNYSE:HSP
28/04/201509:51Dow Jones NewsHospira Profit Easily Tops Expectations as Injectables Remain StrongNYSE:HSP
28/04/201509:20Dow Jones NewsPfizer Trims Outlook on Stronger DollarNYSE:HSP
28/04/201509:02Edgar (US Regulatory)Quarterly Report (10-q)NYSE:HSP
28/04/201508:39Edgar (US Regulatory)Current Report Filing (8-k)NYSE:HSP
28/04/201508:30PR Newswire (US)Hospira Reports First-Quarter 2015 ResultsNYSE:HSP
24/04/201508:41PR Newswire (US)Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on ExtrapolationNYSE:HSP
22/04/201522:17Dow Jones NewsMeet Pharma's Newest Movers and Shakers, Driving M&ANYSE:HSP
13/04/201504:30PR Newswire (US)Hope for Greater Access for Patients to Biosimilar MedicinesNYSE:HSP
10/04/201510:31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NYSE:HSP
07/04/201517:52Dow Jones NewsHospira Gets Warning Letter on Quality Issues at Italy PlantNYSE:HSP
07/04/201517:30PR Newswire (US)Hospira to Announce First-Quarter 2015 Results on April 28, 2015NYSE:HSP
01/04/201517:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:HSP
30/03/201512:33PR Newswire (Canada)INFLECTRA™ (Infliximab) de Hospira est désormais offert au CanadaNYSE:HSP
30/03/201512:30PR Newswire (US)Hospira's INFLECTRA™ (Infliximab) Now Available in CanadaNYSE:HSP
27/03/201510:00PR Newswire (US)Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalenc...NYSE:HSP
23/03/201518:44The Motley FoolThis Market Could Grow 6250% in 10 YearsNYSE:HSP
23/03/201508:02The Motley Fool3 Big Pharma Stocks Wall Street Is Wrong AboutNYSE:HSP
20/03/201517:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:HSP
20/03/201517:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:HSP
06/03/201513:39PR Newswire (US)Hospira Statement on FDA Approval of the First Biosimilar in the United StatesNYSE:HSP
27/02/201520:20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NYSE:HSP
25/02/201520:15Dow Jones NewsGeneric Copies of Remicade Go on Sale in EuropeNYSE:HSP
23/02/201513:06GlobeNewswire Inc.UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Hospira Inc. of Class Action Against the Board of the Co...NYSE:HSP
19/02/201509:07PR Newswire (US)Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel diseaseNYSE:HSP
18/02/201517:34Business WireHOSPIRA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNYSE:HSP
17/02/201522:30Business WireHOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. (HSP) Board of Directors in ...NYSE:HSP
 Apresentando as notícias mais relevantes sobre:NYSE:HSP